Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiphospholipid antibody syndrome].

S Musini1, G M Savazzi

  • 1Dipartimento di Clinica Medica e Nefrologia, Università, Parma.

Recenti Progressi in Medicina
|April 11, 2001
PubMed
Summary

Antiphospholipid antibodies (aPL) increase the risk of blood clots and pregnancy loss. This case highlights how abnormal lab results can point to uncommon aPL syndromes despite mild symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain atrophy in uremia. Research of the causes and future perspectives.

Nephron·2002
Same author

Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis.

Nephron·2001
Same author

[Amyloidosis and renal failure].

Recenti progressi in medicina·1999
Same author

Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients.

Nephron·1999
Same author

[Treatment of arterial hypertension in diabetic nephropathy. Certainties and hypotheses].

Presse medicale (Paris, France : 1983)·1996
Same author

[The feasibility and current limits in the prevention of diabetic nephropathy].

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·1996

Area of Science:

  • Immunology
  • Hematology
  • Clinical Medicine

Background:

  • Antiphospholipid antibodies (aPL) are diverse immunoglobulins, including lupus anticoagulant and anticardiolipin antibodies.
  • aPL are associated with high risks of thrombosis, thrombocytopenia, and recurrent fetal loss.

Observation:

  • This case report features mild symptoms and minimal bleeding.
  • Significant abnormal laboratory findings were observed, prompting further investigation.

Findings:

  • Antiphospholipid antibodies can exhibit in vitro anticoagulant effects but may promote clotting in vivo.
  • The study investigates an uncommon syndrome associated with aPL, characterized by discrepant clinical and laboratory findings.

Implications:

  • Early suspicion of aPL is crucial in unexplained thrombophilia and prolonged coagulation assays.
  • Understanding the procoagulant effects of aPL in vivo is vital for patient management.
  • This case underscores the importance of laboratory diagnostics in identifying rare aPL-related disorders.

Related Experiment Videos